drugset / Trial / NCT00991016
Single and Multiple Dose Safety, Tolerability, and Pharmacokinetics Study of PF-04805712 in Healthy Volunteers
RandomizedCrossoverDouble-blindBasic science
Summary
To assess the safety and tolerability of escalating single and multiple doses of the compound in healthy volunteers
Timeline
- Start
- 2009-10
- Primary completion
- 2010-08
- Completion
- 2010-08
Outcome
Outcome not reported
Stopped: “B1411001 was terminated after completion of 4 cohorts of the multiple ascending dose phase, as additional data were deemed unnecessary. No safety concerns.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-04805712 | Unknown | 30 mg | Oral |
Indications
No indication recorded.